- Home
- TLSA vs INFU Comparison
TLSA vs INFU Comparison
Compare TLSA & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- INFU
- Stock Information
- Founded
- TLSA 2013
- INFU 2005
- Country
- TLSA United Kingdom
- INFU United States
- Employees
- TLSA N/A
- INFU N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- INFU Medical/Dental Instruments
- Sector
- TLSA Health Care
- INFU Health Care
- Exchange
- TLSA Nasdaq
- INFU Nasdaq
- Market Cap
- TLSA 187.0M
- INFU 180.4M
- IPO Year
- TLSA 2000
- INFU N/A
- Fundamental
- Price
- TLSA $1.97
- INFU $10.32
- Analyst Decision
- TLSA
- INFU Strong Buy
- Analyst Count
- TLSA 0
- INFU 2
- Target Price
- TLSA N/A
- INFU $13.50
- AVG Volume (30 Days)
- TLSA 455.3K
- INFU 248.8K
- Earning Date
- TLSA 05-06-2025
- INFU 11-06-2025
- Dividend Yield
- TLSA N/A
- INFU N/A
- EPS Growth
- TLSA N/A
- INFU 2168.02
- EPS
- TLSA N/A
- INFU 0.24
- Revenue
- TLSA N/A
- INFU $139,886,000.00
- Revenue This Year
- TLSA N/A
- INFU $9.07
- Revenue Next Year
- TLSA N/A
- INFU $6.55
- P/E Ratio
- TLSA N/A
- INFU $43.78
- Revenue Growth
- TLSA N/A
- INFU 8.13
- 52 Week Low
- TLSA $0.63
- INFU $4.61
- 52 Week High
- TLSA $2.60
- INFU $11.04
- Technical
- Relative Strength Index (RSI)
- TLSA 53.23
- INFU 57.83
- Support Level
- TLSA $1.90
- INFU $10.05
- Resistance Level
- TLSA $2.18
- INFU $10.59
- Average True Range (ATR)
- TLSA 0.17
- INFU 0.39
- MACD
- TLSA 0.02
- INFU -0.07
- Stochastic Oscillator
- TLSA 46.48
- INFU 47.97
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.